UBS Maintains a 'Neutral' on Saks Inc. (SKS); Bumping Numbers After Q2 Results
Get Alerts SKS Hot Sheet
Price: $15.99 --0%
Rating Summary:
0 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
0 Buy, 7 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
UBS maintains a 'Neutral' on Saks Inc. (NYSE: SKS) price target of $12.00 (from $11.00).
Analyst, Michael Binetti, said, "We are raising our ‘12E EPS to $0.51 from $0.46—reflecting a $0.03 beat and lowered share count in 2Q. We are raising our 3Q est to $0.13 from $0.12 based on lower shares (was 198.5m, now 194m) but lowering our GM forecast (to flat YOY vs +10bp previously). Our ’12 est is based on 5.6% & 4.8% SSS growth in 3Q & 4Q."
Remain Neutral on more balanced risk/reward.
For an analyst ratings summary and ratings history on Saks Inc. click here. For more ratings news on Saks Inc. click here.
Shares of Saks Inc. closed at $11.52 yesterday.
Analyst, Michael Binetti, said, "We are raising our ‘12E EPS to $0.51 from $0.46—reflecting a $0.03 beat and lowered share count in 2Q. We are raising our 3Q est to $0.13 from $0.12 based on lower shares (was 198.5m, now 194m) but lowering our GM forecast (to flat YOY vs +10bp previously). Our ’12 est is based on 5.6% & 4.8% SSS growth in 3Q & 4Q."
Remain Neutral on more balanced risk/reward.
For an analyst ratings summary and ratings history on Saks Inc. click here. For more ratings news on Saks Inc. click here.
Shares of Saks Inc. closed at $11.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Eclat Textile Co Ltd (1476:TT) PT Lowered to NT$547 at Macquarie
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share